Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)
Uwe Wagner, Andreas du Bois, Jacobus Pfisterer, Jens Huober, Sybille Loibl, Hans-Joachim Lück, Jalid Sehouli, Martina Gropp, Anne Stähle, Barbara Schmalfeldt, Werner Meier, Christian JackischVolume:
105
Year:
2007
Language:
english
Pages:
6
DOI:
10.1016/j.ygyno.2006.10.053
File:
PDF, 146 KB
english, 2007